Patents Assigned to Enterprise Ireland (trading as BioResearch Ireland) and National University of Ireland, Cork.
  • Publication number: 20030215467
    Abstract: A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
    Type: Application
    Filed: March 17, 2003
    Publication date: November 20, 2003
    Applicant: Enterprise Ireland (Trading as Bioresearch Ireland and National University of Ireland, Cork.
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan
  • Publication number: 20030170217
    Abstract: A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
    Type: Application
    Filed: March 3, 2003
    Publication date: September 11, 2003
    Applicant: Enterprise Ireland (Trading as Bioresearch Ireland and National University of Ireland, Cork.
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan
  • Publication number: 20030113809
    Abstract: An in vitro test for testing the immunomodulatory especially anti-inflammatory or pro-inflammatory effect of a test material comprises placing a microporous support having a monolayer of epithelial cells therein in contact with a nutrient medium in a culture well. Cells of the immune system such as peripheral blood mononuclear cells are introduced into the medium and a test material is also introduced into the nutrient medium. A change in an immunological marker, especially a cytokine, particularly TNF&agr; or IL-8 in response to the test material is determined. The test material may be a strain of Lactobacillus or Bifidobacterium or other material which may be a probiotic.
    Type: Application
    Filed: June 18, 2002
    Publication date: June 19, 2003
    Applicant: Enterprise Ireland (trading as BioResearch Ireland) and National University of Ireland, Cork.
    Inventors: John Kevin Collins, Liam O'Mahony